for

Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs REMONY for Advanced Health Monitoring and Heatstroke Safety

TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM…

2 months ago

Finalists in 22nd Stevie Awards for Women in Business Announced

World's Top Honors for Women Professionals to Be Presented in New York City on November 10 FAIRFAX, Va., Sept. 18,…

2 months ago

Charity Urges People to Step Up for the Planet and Take Part in the 2025 Rainforest Run

Thursday 18 September, 2025 This September, hundreds of people across the world will lace up their trainers for the Rainforest…

2 months ago

Laura Villars, Swiss racing driver, becomes the first woman to run for FIA President

PARIS, Sept. 18, 2025 /PRNewswire/ -- Laura Villars, Swiss racing driver aged 28, officially announces her candidacy for the Presidency…

2 months ago

Index Exchange Receives Frost & Sullivan’s 2025 Global New Product Innovation Recognition for Leadership in Supply-Side Platforms

Index Exchange earns acclaim for advancing innovation, transparency, and customer-centric solutions within the supply-side platform ecosystem.  SAN ANTONIO, Sept. 17,…

2 months ago

Funds Advised by Convergent Finance to Acquire 10.3% Stake in Knowledge Marine & Engineering Works Limited for USD 27.4 Million

Investment to be used for expansion of marine vessels fleet for business growth Company to capitalize on its unique positioning…

2 months ago

GIGABYTE Announces the Availability of its AI-enhanced AORUS X870E X3D Series Motherboards for AMD Ryzen X3D Processors

TAIPEI, Sept. 17, 2025 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, announces that the AORUS X870E X3D series motherboards are…

2 months ago

Golfers tee off for a great cause

Wednesday 17 September, 2025 Weston Turville Golf Club was buzzing with energy as the Chilterns Neuro Centre hosted its Charity…

2 months ago

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…

2 months ago

New Survey Shows AI Has Become a Strategic Imperative for HR: 9 in 10 Leaders Confident in Its Use

Survey of 1,340 HR leaders shows widespread AI use, prioritizing solutions that value employee trustSAN FRANCISCO--(BUSINESS WIRE)--#HealthWayFinding--Transcarent, the One Place…

2 months ago